 November 29, 2007
|
Treating Anal Lesions Nonsurgically
Nonsurgical treatment of precancerous anal lesions using an infrared coagulator (IRC) has been found safe and effective in a small study, according to an article in the Journal of Immune Deficiency Syndromes.
|
|
November 28, 2007
|
Sculptra Modestly Improves Facial Wasting
Treatment with Sculptra (poly-L-lactic acid), one of two FDA-approved treatments for facial fat loss, results in only modest increases in tissue thickness but high patient satisfaction, according to a study published in the December 15 issue of the Journal of Acquired Immune Deficiency Syndromes.
|
|
November 27, 2007
|
Fosamax Safe and Effective for Bone Mineral Loss
Fosamax (alendronate sodium), added to calcium and vitamin D supplementation, is a safe and effective treatment option for HIV-positive people with bone mineral loss, according to final data from a clinical trial published in the November 30 issue of AIDS.
|
|
November 26, 2007
|
AIDS Activism Training in Atlanta, December 7 & 8
The AIDS Treatment Activists Coalition (ATAC), a national coalition of AIDS activists, will be conducting a training workshop on activism for HIV prevention, drug development and treatment access in Atlanta on December 7 and 8.
|
|
November 20, 2007
November 16, 2007
November 14, 2007
|
Suppressing HIV Doesn’t Stop Immune Activation
Signs of immune over-activation has been found in the spinal fluid of volunteers who have suppressed HIV to undetectable levels for four years, according to a newly published study in the Journal of Infectious Diseases.
|
|
November 13, 2007
|
FDA Approves Low-Dose Kaletra for Kids
The Food and Drug Administration has approved a new low-dose Kaletra (lopinavir/ritonavir) tablet, sold as Aluvia in many other parts of the world, for use in HIV-positive children, according to the drug’s maker, Abbott.
|
|
|
Herpes Drug Fights HIV Too
The anti-herpes drug Valtrex (valacyclovir) has been found to lower HIV viral load in the blood and genital secretions of men with underlying herpes simplex vius-2 (HSV-2) infection, according to a report on a study from AIDSmap.
|
|
November 12, 2007
|
People With Kidney Disease Undertreated for HIV
People with both HIV and kidney disease are not being treated appropriately for HIV, leading to greater death rates, say researchers of a new study published in Clinical Infectious Diseases.
|
|
|
GSK Sues Abbott Over Norvir Price Hike
GlaxoSmithKline Plc filed a lawsuit against Abbott on Friday, November 9, over the price of Norvir, a boosting agent that works in conjunction with protease inhibitors.
|
|
November 09, 2007
November 08, 2007
|
New Worries With AIDS Vaccine
Previous immunity to adenovirus 5 (Ad5), a common cold virus, may explain why volunteers receiving Merck’s preventive HIV vaccine may have been more likely to become infected with HIV than those receiving placebo injections, suggest researchers associated with the international STEP study.
|
|
November 07, 2007
|
Half of Patients Had AIDS at Time of HIV Diagnosis
A new study has found that half of people in the Veteran’s Administration (VA) medical system who tested HIV positive already had AIDS at the time of their diagnosis, according to an announcement by researchers at Yale and Yeshiva University.
|
|
November 06, 2007
|
Major Lab Company Licenses Tropism Test
Quest Diagnostics, the nation’s largest diagnostic testing company, has announced that it will begin offering an HIV tropism test, Pathway Diagnostics’ SensiTrop assay.
|
|
November 05, 2007
November 02, 2007
|
